Noteworthy - Pharmaceutical Executive

ADVERTISEMENT

Noteworthy

What Would Britain's EU Exit Mean for Drugmakers?

February 25, 2014

The possibility of a future "Brexit" — a British exit from the EU — has been exercising the world of medicines, writes Peter O'Donnell.

Pharm Exec Global Digest — Sales & Marketing Special

February 12, 2014

In the latest issue of PEGD: Face-to-Face Meetings in the Digital Age; the US Rx Rep in the Obamacare Era; the Future of the iPad — And more

Innovation and Market Growth in Brazil

February 10, 2014

Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator. Hellen Berger reports.

Pharm Exec's Emerging Pharma Leaders 2014 — Nominate Now

February 7, 2014

It's time for you to tell us who you think should receive Pharm Exec's 2014 Emerging Pharma Leadership Award. Read more for details of how to nominate a colleague — or yourself.

Growing Pains: The European Medicines Agency at 20

February 3, 2014

Reflector looks at the growing pains of the European Medicine Agency (EMA) as it faces the key policy challenges of 2014.

Managed Markets: Positioning Your Product For Success with Pull Through Strategies

February 1, 2014

A patient-centric approach to drug development delivers the benefits that actually create value.

Product Positioning 2.0

February 1, 2014

Industry and market transformations have dramatically altered when and how products should be positioned for launch, writes Stan Bernard.

Drug Coverage, Costs Under Scrutiny

February 1, 2014

Benefits offered by insurance plans on health exchanges and through Medicare are raising concerns about patient access to needed therapies, writes Jill Wechsler.

Takeda's Oncology Taskmaster

February 1, 2014

Millennium Takeda's new president, Anna Protopapas, explains the life choices that brought her from Cyprus to Cambridge—and a lead position in the hotly contested search to make cancer a treatable disease.

ADVERTISEMENT

Click here